NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $115 | -83.9% | 200 | -80.3% | 0.00% | – |
Q1 2023 | $713 | -68.9% | 1,015 | 0.0% | 0.00% | – |
Q4 2022 | $2,294 | -42.6% | 1,015 | -14.7% | 0.00% | – |
Q3 2022 | $4,000 | -69.2% | 1,190 | -63.8% | 0.00% | – |
Q2 2022 | $13,000 | -23.5% | 3,291 | 0.0% | 0.00% | – |
Q1 2022 | $17,000 | -52.8% | 3,291 | +24.6% | 0.00% | – |
Q4 2021 | $36,000 | -23.4% | 2,641 | 0.0% | 0.00% | – |
Q3 2021 | $47,000 | +176.5% | 2,641 | +160.2% | 0.00% | – |
Q2 2021 | $17,000 | -15.0% | 1,015 | 0.0% | 0.00% | – |
Q1 2021 | $20,000 | -41.2% | 1,015 | -49.6% | 0.00% | – |
Q4 2020 | $34,000 | +3.0% | 2,015 | 0.0% | 0.00% | – |
Q3 2020 | $33,000 | -29.8% | 2,015 | 0.0% | 0.00% | – |
Q2 2020 | $47,000 | +161.1% | 2,015 | +98.5% | 0.00% | – |
Q1 2020 | $18,000 | -18.2% | 1,015 | 0.0% | 0.00% | – |
Q4 2019 | $22,000 | +22.2% | 1,015 | 0.0% | 0.00% | – |
Q3 2019 | $18,000 | +260.0% | 1,015 | +407.5% | 0.00% | – |
Q3 2017 | $5,000 | +66.7% | 200 | +15.6% | 0.00% | – |
Q2 2017 | $3,000 | -70.0% | 173 | -72.1% | 0.00% | – |
Q4 2014 | $10,000 | – | 620 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |